Clinical analysis of sirolimus as an alternative GVHD prophylaxis for patients with kidney injury undergoing allo-HSCT  

作　　者：孙葳 SUN Wei(Peking Univ People's Hosp,Peking Univ Hematol Instit,Natl Clin Res Center,Hematol Dis,Beijing Key Lab,Hematopoiet Stem Cell Transplant,Beijing 100044)

机构地区：[1]Peking Univ People's Hosp,Peking Univ Hematol Instit,Natl Clin Res Center,Hematol Dis,Beijing Key Lab,Hematopoiet Stem Cell Transplant,Beijing 100044

出　　处：《China Medical Abstracts(Internal Medicine)》2024年第1期55-56,共2页中国医学文摘（内科学分册（英文版）

摘　　要：Objective To explore the feasibility of sirolimus as an alternative graft versus host disease (GVHD)prophylaxis in patients with kidney injury after allogeneic hematopoietic stem cell transplantation (allo-HSCT).Methods Medical records of 11 patients in Peking University People’s Hospital from 1 August 2008 to 31October 2022,who received sirolimus instead of cyclosporine to prevent GVHD.

关 键 词：PATIENTS KIDNEY GVHD 

分 类 号：R457.7[医药卫生—治疗学]